2. Academic Validation
  3. Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders

Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders

  • ACS Med Chem Lett. 2026 Apr 27;17(5):1033-1034. doi: 10.1021/acsmedchemlett.6c00208.
Ram W Sabnis 1,  Anika R Sabnis 2
Affiliations

Affiliations

  • 1 Arclin USA LLC, 1150 Sanctuary Parkway, Suite 100, Alpharetta, Georgia 30009, United States.
  • 2 Department of Neurologic Surgery, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, United States.
PMID: 42157830 DOI: 10.1021/acsmedchemlett.6c00208
Abstract

Provided herein are novel indoline derivatives serotonergic psychedelic agents as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating psychosis, mental illness and central nervous system (CNS) disorders and processes for preparing such compounds.

Figures
Products